Evidence map›Paper›PMID 41600463›Full record

ArticleSensors (Basel, Switzerland)2026

REEV SENSE IMUs for Spatiotemporal Gait Analysis in Post-Stroke Patients: Validation Against Optical Motion Capture.

Thibault Marsan, Sacha Clauzade, Xiang Zhang, Nicolas Grandin, Tatiana Urman, Evan Linton, Samy Sibachir, Catherine E Ricciardi, Robin Temporelli

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Walking as a Window to the Brain: Redefining Gait in Neurology.Medical sciences (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thibault MarsanREEV SAS, 31000 Toulouse, France.
Sacha ClauzadeREEV SAS, 31000 Toulouse, France.
Xiang ZhangCenter for Clinical and Translational Research, Massachusetts Institute of Technology, Cambridge, MA 02319, USA.ORCID 0000-0002-3130-8337
Nicolas GrandinREEV SAS, 31000 Toulouse, France.ORCID 0009-0002-9498-7792
Tatiana UrmanCenter for Clinical and Translational Research, Massachusetts Institute of Technology, Cambridge, MA 02319, USA.
Evan LintonCenter for Clinical and Translational Research, Massachusetts Institute of Technology, Cambridge, MA 02319, USA.ORCID 0000-0001-5627-1318
Samy SibachirREEV SAS, 31000 Toulouse, France.
Catherine E RicciardiCenter for Clinical and Translational Research, Massachusetts Institute of Technology, Cambridge, MA 02319, USA.
Robin TemporelliREEV SAS, 31000 Toulouse, France.

Funding

Tufts Clinical and Translational Science Institute (Clinical Trial Design Labs Supplement)UM1TR004398 · NCATS · TUFTS UNIVERSITY BOSTON · PI Harry P. Selker · 2023 to 2026
$44.5M
NCATS NIH HHS UM1TR004398
6 · The paper itself

Abstract

Objective gait assessment is essential for post-stroke rehabilitation monitoring, yet optical motion capture systems remain inaccessible to most clinical settings due to cost and infrastructure constraints. This study assessed the validity of the REEV SENSE IMU for measuring spatiotemporal gait parameters in post-stroke individuals and evaluated assistive device effects on measurement accuracy. Twenty chronic post-stroke participants were enrolled, and fourteen completed the study (ten without an assistive device, four using a cane) after applying pre-defined exclusion criteria (walking speed <0.28 m/s,

Indexed as

GaitGait AnalysisStrokeStroke RehabilitationAgedFemaleHumansMaleMiddle AgedMotion CaptureReproducibility of ResultsWalkingassistive devicesclinical validationspatiotemporal parametersstroke survivorswearable sensors

Identifiers

PMID41600463
PMCPMC12845817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.